The Effect of Nonstress Test Device Noise Level on Stress Parameters in Primiparous Pregnant Women

Sponsor
Halic University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05488704
Collaborator
(none)
44
1
89.8
0.5

Study Details

Study Description

Brief Summary

Introduction: Prenatal tests can increase the stress levels of pregnant women. One of the tests performed to evaluate fetal health during pregnancy is the Nonstress Test (NST).

Objective: To evaluate the effect of NST device noise level on stress parameters in primiparous pregnant women.

Method: A randomized controlled, prospective study was conducted with 44 pregnant women in a State Hospital in Istanbul/Turkey between 01.02.2021 and 01.10.2021.

Personal Information Form, Spielberger State Anxiety Inventory, Hillrom Welch Allyn Connex Spot Monitor, Gluco Dr Glucometer, Extech SL 400 Personal Noise Dosimeter, Sennheiser HD 450BT ANC Over-Ear Bluetooth Headset, Eppendorf Tube, Philips Avalon FM20 NST were used to collect data. A p value of <.05 was considered significant in the statistical evaluation.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Stress Parameters Measurement

Detailed Description

A number of tests are used to evaluate fetal health during pregnancy. One of these tests is the NST. NST is a frequently used fetal evaluation method in gynecology clinics/services during pregnancy and labor. The sound levels of the NST device are created in a way that the healthcare professional can adjust, and at the same time, the average dB(A) range of the sound levels is not known. It has been stated in many studies that noise causes stress in individuals, and that the stress experienced in pregnant women is associated with negative maternal and neonatal outcomes. It is important to evaluate NST noise levels and stress parameters in order to maintain NST, which is a frequently used fetal evaluation method in the prenatal period in clinical practice, without causing maternal stress and to prevent possible negative consequences. With the information to be obtained in line with the results of the research, it is aimed to maintain the noise level of the NST device used by the midwives in the most appropriate sound range for the pregnant women and thus to ensure that the stress levels of the pregnant women are at the lowest level during the procedure.

This study was carried out to evaluate the effect of NST device noise level on stress parameters in primiparous pregnant women.

Study Design

Study Type:
Observational
Actual Enrollment :
44 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
The Effect of Nonstress Test Device Noise Level on Stress Parameters in Primiparous Pregnant Women
Actual Study Start Date :
Feb 1, 2021
Actual Primary Completion Date :
Oct 1, 2021
Anticipated Study Completion Date :
Jul 28, 2028

Arms and Interventions

Arm Intervention/Treatment
CONTROL GROUP

Control Group [NST device volume turned off]

Diagnostic Test: Stress Parameters Measurement
Pre-Test (0-2 minutes before NST starts) - Measurement of vital parameters (Pre-Test) Glucose measurement Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory • Starting NST by controlling the noise level Interim Test-(NST 10th minute) - Measurement of vital parameters (Intermediate Test) Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory • Termination of NST after 20 minutes Final Test(within 0-2 minutes after NST is over) Measurement of vital parameters Glucose measurement Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory After Data Collection - Recording of data Centrifugation and analysis of saliva samples taken

Intervention Group I

Intervention Group I [NST device volume 1-35 dB(A)]

Diagnostic Test: Stress Parameters Measurement
Pre-Test (0-2 minutes before NST starts) - Measurement of vital parameters (Pre-Test) Glucose measurement Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory • Starting NST by controlling the noise level Interim Test-(NST 10th minute) - Measurement of vital parameters (Intermediate Test) Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory • Termination of NST after 20 minutes Final Test(within 0-2 minutes after NST is over) Measurement of vital parameters Glucose measurement Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory After Data Collection - Recording of data Centrifugation and analysis of saliva samples taken

Intervention Group II

Intervention Group II [NST device volume 36-60 dB(A)]

Diagnostic Test: Stress Parameters Measurement
Pre-Test (0-2 minutes before NST starts) - Measurement of vital parameters (Pre-Test) Glucose measurement Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory • Starting NST by controlling the noise level Interim Test-(NST 10th minute) - Measurement of vital parameters (Intermediate Test) Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory • Termination of NST after 20 minutes Final Test(within 0-2 minutes after NST is over) Measurement of vital parameters Glucose measurement Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory After Data Collection - Recording of data Centrifugation and analysis of saliva samples taken

Intervention Group III

Intervention Group III [61 dB( A) and above]

Diagnostic Test: Stress Parameters Measurement
Pre-Test (0-2 minutes before NST starts) - Measurement of vital parameters (Pre-Test) Glucose measurement Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory • Starting NST by controlling the noise level Interim Test-(NST 10th minute) - Measurement of vital parameters (Intermediate Test) Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory • Termination of NST after 20 minutes Final Test(within 0-2 minutes after NST is over) Measurement of vital parameters Glucose measurement Taking Salivary Cortisol and Saliva ACTH samples Filling the Spielberger State Anxiety Inventory After Data Collection - Recording of data Centrifugation and analysis of saliva samples taken

Outcome Measures

Primary Outcome Measures

  1. Does increasing the noise level of the NST device affect If salivary cortisol levels [01.02.2021-01.10.2021]

    Data collection tool used to reach this outcome: Saliva cortisol was measured by a microplate reader with commercially available kit based on ELISA.

  2. Does increasing the noise level of the NST device affect If salivary ACTH levels [01.02.2021-01.10.2021]

    Data collection tool used to reach this outcome: Saliva ACTH was measured by a microplate reader with commercially available kit based on ELISA.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:
  • Voluntarily agreeing to participate in the research,

  • Over 18 years old,

  • Literate,

  • Fluent in Turkish

  • 32-42 of your pregnancy. in the week,

  • Having a healthy pregnancy,

  • No adrenal insufficiency,

  • No problems with hearing,

  • No psychiatric diagnosis during or before pregnancy,

  • No history of infertility,

  • Coming to routine pregnancy and NST control,

  • Have not had any food or drink for at least two hours before the procedure,

  • Primiparous pregnant women without contractions were included.

Exclusion Criteria:
  • Pregnant women whose contractions are detected during the NST procedure,

  • Pregnant women with deceleration detected in the NST procedure were excluded from the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bakırköy Dr. Sadi Konuk Training and Research Hospital Istanbul Turkey

Sponsors and Collaborators

  • Halic University

Investigators

  • Study Director: Ayşenur Turan, PhD, Lecturer

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Halic University
ClinicalTrials.gov Identifier:
NCT05488704
Other Study ID Numbers:
  • 35620
First Posted:
Aug 4, 2022
Last Update Posted:
Aug 4, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Halic University

Study Results

No Results Posted as of Aug 4, 2022